Tyra Biosciences, Inc.
TYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $569,901 | $551,830 | $818,356 |
| - Cash | $61,951 | $98,490 | $100,721 | $91,966 |
| + Debt | $5,463 | $6,023 | $6,122 | $6,222 |
| Enterprise Value | – | $477,434 | $457,231 | $732,612 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$29,737 | -$31,312 | -$31,707 | -$29,600 |
| % Margin | – | – | – | – |
| Net Income | -$29,868 | -$28,098 | -$28,147 | -$25,571 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.5 | -0.47 | -0.47 | -0.43 |
| % Growth | -6.4% | 0% | -9.3% | – |
| Operating Cash Flow | -$22,380 | -$23,680 | -$25,458 | -$19,590 |
| Capital Expenditures | -$39 | -$31 | -$14 | -$6 |
| Free Cash Flow | -$22,419 | -$23,711 | -$25,472 | -$19,596 |